+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Regenerative Medicine Partnering 2014 to 2019

  • ID: 3162392
  • Report
  • Region: Global
  • 590 Pages
  • CurrentPartnering
1 of 6

FEATURED COMPANIES

  • 2M
  • Bioverativ
  • Epic Sciences
  • Kerecis
  • OSE Immunotherapeutics
  • Takeda Pharmaceutical
  • MORE

The Global Regenerative Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies.

  • Trends in regenerative medicine
  • Deal terms analysis
  • Partnering agreement structure
  • Partnering contract documents
  • Top deals by value
  • Most active dealmakers
  • Average deal terms for regenerative medicine and stem cells

The report provides a detailed understanding and analysis of how and why companies enter Regenerative Medicine partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Regenerative Medicine agreements announced in the life sciences since 2014.

The report takes the reader through a comprehensive review Regenerative Medicine deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Regenerative Medicine partnering deals.

The report presents financial deal term values for Regenerative Medicine deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Regenerative Medicine partnering field; both the leading deal values and most active Regenerative Medicine dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 890 online deal records of actual Regenerative Medicine deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Regenerative Medicine dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Regenerative Medicine dealmaking since 2014, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Regenerative Medicine deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Regenerative Medicine dealmaking with a brief summary followed by a comprehensive listing of Regenerative Medicine deals announced by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Regenerative Medicine partnering deals signed and announced since Jan 2014, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Regenerative Medicine partnering deals signed and announced since Jan 2014. The chapter is organized by specific Regenerative Medicine technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Regenerative Medicine partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Regenerative Medicine partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Regenerative Medicine technologies and products.

Key benefits

Global Regenerative Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

  • In-depth understanding of Regenerative Medicine deal trends since 2014
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of Regenerative Medicine agreements with numerous real life case studies
  • Detailed access to actual Regenerative Medicine contracts entered into by leading biopharma companies
  • Identify most active Regenerative Medicine dealmakers since 2014
  • Insight into terms included in a Regenerative Medicine partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Regenerative Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Regenerative Medicine trends and structure of deals entered into by leading companies worldwide.

Regenerative Medicine Partnering Terms and Agreements includes:

  • Trends in Regenerative Medicine dealmaking in the biopharma industry since 2014
  • Analysis of Regenerative Medicine deal structure
  • Access to headline, upfront, milestone and royalty data
  • Case studies of real-life Regenerative Medicine deals
  • Access to Regenerative Medicine contract documents
  • Leading Regenerative Medicine deals by value since 2014
  • Most active Regenerative Medicine dealmakers since 2014

In Global Regenerative Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Regenerative Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 890 Regenerative Medicine deals.

Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 2M
  • Bioverativ
  • Epic Sciences
  • Kerecis
  • OSE Immunotherapeutics
  • Takeda Pharmaceutical
  • MORE

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Regenerative Medicine dealmaking
2.1. Introduction
2.2. Regenerative Medicine partnering over the years
2.3. Most active Regenerative Medicine dealmakers
2.4. Regenerative Medicine partnering by deal type
2.5. Regenerative Medicine partnering by therapy area
2.6. Deal terms for Regenerative Medicine partnering
2.6.1 Regenerative Medicine partnering headline values
2.6.2 Regenerative Medicine deal upfront payments
2.6.3 Regenerative Medicine deal milestone payments
2.6.4 Regenerative Medicine royalty rates

Chapter 3 - Leading Regenerative Medicine deals
3.1. Introduction
3.2. Top Regenerative Medicine deals by value

Chapter 4 - Most active Regenerative Medicine dealmakers
4.1. Introduction
4.2. Most active Regenerative Medicine dealmakers
4.3. Most active Regenerative Medicine partnering company profiles

Chapter 5 - Regenerative Medicine contracts dealmaking directory
5.1. Introduction
5.2. Regenerative Medicine contracts dealmaking directory

Chapter 6 - Regenerative Medicine dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices
Appendix 1 - Regenerative Medicine deals by company A-Z
Appendix 2 - Regenerative Medicine deals by stage of development
Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation
Appendix 3 - Regenerative Medicine deals by deal type
Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty
Appendix 4 - Regenerative Medicine deals by therapy area
Appendix 5 -Deal type definitions

Table of figures
Figure 1: Regenerative Medicine partnering since 2014
Figure 2: Active Regenerative Medicine dealmaking activity
Figure 3: Regenerative Medicine partnering by deal type since 2014
Figure 4: Regenerative Medicine partnering by disease type since 2014
Figure 5: Regenerative Medicine deals with a headline value
Figure 6: Regenerative Medicine deals with an upfront value
Figure 7: Regenerative Medicine deals with a milestone value
Figure 8: Regenerative Medicine deals with a royalty rate value
Figure 9: Top Regenerative Medicine deals by value since 2014
Figure 10: Most active Regenerative Medicine dealmakers since 2014
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 2M
  • Bioverativ
  • Epic Sciences
  • Kerecis
  • OSE Immunotherapeutics
  • Takeda Pharmaceutical
  • MORE
Global Regenerative Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts provides the reader with the following key benefits:
  • In-depth understanding of Regenerative Medicine deal trends since 2014
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of Regenerative Medicine agreements with numerous real life case studies
  • Detailed access to actual Regenerative Medicine contracts entered into by leading biopharma companies
  • Identify most active Regenerative Medicine dealmakers since 2014
  • Insight into terms included in a Regenerative Medicine partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Note: Product cover images may vary from those shown
5 of 6
  • 2M
  • 3D Systems
  • 3SBio
  • 4D Molecular Therapeutics
  • A*STAR Agency for Science
  • Technology and Research
  • A*STAR Genome Institute of Singapore
  • Aastrom Biosciences
  • AAVLife
  • Abbvie
  • Abby Grace Foundation
  • AbCellera
  • Abeona Therapeutics
  • Abingworth Management
  • Ablynx
  • Abzena
  • Accellta
  • Accenture
  • Access BIO
  • AccuResearch
  • ACEA Biosciences
  • Actinium Pharmaceuticals
  • Adaptimmune
  • Adaptive Biotechnologies
  • Addex Therapeutics
  • Advanced Biological Laboratories
  • Advanced Biologics
  • Advanced BioMatrix
  • Advanced BioScience Laboratories
  • Advanced Biotherapeutics Consulting
  • Aelan Cell Technologies
  • AGC Asahi Glass
  • Agensys
  • Agilent Technologies
  • Agilis Biotherapeutics
  • Agrivida
  • AGTC
  • AiVita Biomedical
  • Akashi Therapeutics
  • Akouos
  • Akron Biotechnology
  • Alcyone Lifesciences
  • Alder Biopharmaceuticals
  • Alkahest
  • Allele Biotechnology and Pharmaceuticals
  • Allergan
  • Alliance for Regenerative Medicine
  • Alliqua Biomedical
  • Allogene Therapeutics
  • Almog Diagnostic
  • Alnylam Pharmaceuticals
  • Alpine Immune Sciences
  • ALS Finding a Cure Foundation
  • Altor BioScience
  • Amarantus BioSciences
  • Amarna Therapeutics
  • Ambys Medicines
  • American Association of Neuromuscular & Electrodiagnostic Medicine
  • American CryoStem
  • American Gene Technologies
  • American Red Cross
  • American society of Hematology
  • AmerisourceBergen
  • Amgen
  • Amicus Therapeutics
  • AmorChem
  • Anagenesis Biotechnologies
  • AnaptysBio
  • Angiocrine Bioscience
  • Angionetics
  • Angiostem
  • Annapurna Therapeutics
  • Anthony Nolan
  • Antibe Therapeutics
  • Apceth
  • Applied BioMath
  • Applied StemCell
  • Apricus Biosciences
  • Araim Pharmaceuticals
  • Aratana Therapeutics
  • Arbele
  • Arbor Biotechnologies
  • Ariad Pharmaceuticals
  • Arthrex
  • Aruvant Sciences
  • Asahi Kasei
  • Asana Medical
  • Ascendance Biotechnology
  • Ascenion
  • Asklepios Biopharmaceutical
  • Aspect Biosystems
  • Association for Frontotemporal Degeneration
  • Astellas Pharma
  • Astem
  • Asterand Bioscience
  • Asterias Biotherapeutics
  • AstraZeneca
  • Atara Biotherapeutics
  • Athersys
  • Atvio Biotech
  • Auburn University
  • Audentes Therapeutics
  • Audion Therapeutics
  • Aurora BioPharma
  • Australian Research Council
  • Autolus
  • Avacta
  • Avactis Biosciences
  • Avalanche Biotechnologies
  • Avalon GloboCare
  • Avellino Labs
  • AveXis
  • Avita Medical
  • Avrobio
  • Avvinity Therapeutics
  • Axiogenesis
  • Axis Therapeutics
  • Axovant Sciences
  • Axxam
  • Azellon Cell Therapeutics
  • Aziyo Biologics
  • B-MoGen Biotechnologies
  • Bacterin International
  • Bassett Salon Solutions
  • Bayer
  • Bayer USA Foundation
  • Baylor College
  • Baylor College of Medicine
  • Baylor Research Institute
  • B Braun
  • B Braun CeGaT
  • Beckman Research Institute of City of Hope
  • Beijing Genomics Institute (BGI)
  • Beike Biotech
  • Bellicum Pharmaceuticals
  • Benitec Biopharma
  • Berkshire Sterile Manufacturing
  • Berlin-Brandenburg Center for Regenerative Therapies
  • Beta-O2
  • Be The Match BioTherapies
  • Beyond Type 1
  • Bio-Techne
  • Bio-Tissue
  • BioAtla
  • BioBridge Global
  • BioCanRx
  • BioCardia
  • BioDlogics
  • Biogen
  • BioHeart
  • BioInvent
  • BioLamina
  • BioLife Solutions
  • Biological Industries
  • biologistex CCM
  • Biomed
  • Biomedical Advanced Research and Development Authority
  • Biomedical Catalyst Fund (UK)
  • BioMed X Innovation Center
  • Bionic Sight
  • BioRestorative Therapies
  • Biosafe
  • Biosequel
  • Biotechnology and Biological Sciences Research Council (BBSRC)
  • Biotech Products Services & Research
  • BioTime
  • Bioventus
  • Bioverativ
  • Bird Foundation
  • Blood Systems Research Institute
  • Bluebird Bio
  • BlueRock Therapeutics
  • Boehringer Ingelheim
  • Bone Biologics
  • BoneSupport
  • Bone Therapeutics
  • BoyaLife
  • Bpifrance
  • BrainStorm Cell Therapeutics
  • Brammer Bio
  • BriaCell Therapeutics
  • Brigham and Women's Hospital
  • Bright Optical
  • Bristol-Myers Squibb
  • Broad Institute
  • Buck Institute for Age Research
  • Butantan Institute
  • c-LEcta
  • C3i
  • Caladrius Biosciences
  • Calico
  • California Institute for Biomedical Research
  • California Institute for Quantitative Biosciences (QB3)
  • California Institute for Regenerative Medicine
  • California Institute of Technology
  • California State University
  • California Stem Cell
  • Calimmune
  • CAMP4 Therapeutics
  • Canadian National Transplant Research Program
  • Cancer Prevention and Research Institute of Texas
  • Cancer Research Technology
  • Capricor Therapeutics
  • Cardiovascular Cell Therapy Research Network
  • Cardium Therapeutics
  • CareDx
  • CareNet
  • Caribou Biosciences
  • Carnegie Mellon University
  • Carolina BioOncology Institute
  • Cartherics
  • Casebia Therapeutics
  • Case Western Reserve University
  • CASI Pharmaceuticals
  • Castle Creek Pharmaceuticals
  • Catalan Institute of Nanotechnology (ICN)
  • Catalent Pharma Solutions
  • Catapult Therapy TCR
  • CavoGene LifeSciences
  • CEA-Leti
  • Cedars-Sinai Health System
  • Cedars-Sinai Medical Center
  • CeGaT
  • Celdara Medical
  • Celgene
  • Cell2in
  • Celladon
  • Cell and Gene Therapy Catapult
  • Cell Applications
  • Cellaria Biosciences
  • Cell Care Therapeutics
  • Cell Cure Neurosciences
  • Cell Design Labs
  • Cellect Biotechnology
  • Cellectis
  • Cellectis Bioresearch
  • Cellectricon
  • CellforCure
  • CellGenix
  • Celling Biosciences
  • Cell Line Genetics
  • Cell Medica
  • Cell Mogrify
  • CellProThera
  • CellSpring
  • Celltex Therapeutics
  • Cellthera Pharma
  • Cell Therapy
  • Cell Therapy Catapult
  • Cellular Biomedicine
  • Cellular Dynamics International
  • Celtic Biotech
  • Celularity
  • Celyad
  • Censo Biotechnologies
  • Centauri Therapeutics
  • Center for Biomarker Research in Medicine
  • Center for iPS Cells Research and Application
  • Centogene
  • Centre for Commercialization of Regenerative Medicine (CCRM)
  • Centre for Drug Research and Development (CDRD)
  • Cesca Therapeutics
  • Cevec Pharmaceuticals
  • Charite-Universitatsmedizin
  • Chart Industries
  • Children's Hospital Boston
  • Children's Hospital of Philadelphia
  • Children's Hospital of Pittsburgh
  • Children's Research Institute
  • China Cord Blood
  • China Medical System
  • China Southeast University
  • ChromaDex
  • Chugai Pharmaceutical
  • Cimtech
  • Cincinnati Children’s Hospital Medical Center
  • City of Hope
  • Cleara Biotech
  • Clearside Biomedical
  • Clontech Laboratories
  • Cobra Biologics
  • Cognate BioServices
  • Collagen Solutions LLC
  • Collagen Solutions Plc
  • Collplant
  • Colorado State University
  • Columbia University
  • Connecticut Innovations
  • Cook Biotech
  • Cooperative Research Centre for Cell Therapy Manufacturing
  • Copenhagen University Hospital
  • CORD:USE
  • Cord Blood Registry
  • Cordlife
  • Corestem
  • Coriell Institute for Medical Research
  • Cosmotec
  • CPI International
  • Creative Destruction Lab
  • Creative Medical Technologies
  • CRISPR Therapeutics
  • CROMA Pharma
  • CryoPort
  • CureCell
  • Cure Duchenne
  • Cutanogen
  • Cynata Therapeutics
  • Cystic Fibrosis Foundation
  • CytoLumina Technologies
  • Cytonet
  • Cytori Therapeutics
  • CytoSen Therapeutics
  • Cytovant Sciences
  • Daiichi Sankyo
  • Dainippon Sumitomo Pharma
  • Dana-Farber Cancer Institute
  • DanDrit Biotech
  • Dartmouth College
  • Debiotech
  • DefiniGEN
  • Defymed
  • Deloitte
  • Dendreon
  • Department of Defense
  • Department of Veterans Affairs
  • DePuy
  • Derma Sciences
  • Diabeloop
  • Dimension Therapeutics
  • DNA Script
  • Dr. Reddy's Laboratories
  • Dr Allen Wu
  • Duke-NUS Graduate Medical School Singapore
  • Duke University
  • DuPont Pioneer
  • Ecole Polytechnique de Montreal
  • Eden BioCell
  • Editas Medicine
  • Eiger BioPharmaceuticals
  • Elanix Biotechnologies
  • Eli Lilly
  • Elixirgen
  • Elpis Biomed
  • EMD Serono
  • Endocyte
  • enGene
  • Engineering and Physical Sciences Research Council
  • ENPICOM
  • Enterprise Partners Venture Capital
  • Enzyvant Science
  • EpiBone
  • Epica Medical Innovations
  • Epic Sciences
  • Epivax
  • Eppendorf
  • ERS Genomics
  • ES Cell International
  • Eureka Eurostars
  • Eureka Therapeutic
  • European Union
  • Evotec
  • ExCellThera
  • Expression Therapeutics
  • F1 Oncology
  • Fate Therapeutics
  • Federal Ministry of Education and Research (BMBF)
  • Feinstein Institute for Medical Research
  • Feldan Therapeutics
  • Ferring Pharmaceuticals
  • FetoLumina Technologies
  • Fibrocell Science
  • FIT Biotech
  • Five Prime Therapeutics
  • FKD Therapies
  • FloDesign Sonics
  • Florey Institute of Neuroscience and Mental Heath
  • Florida State University
  • Fondazione Telethon
  • Food and Drug Administration (FDA)
  • Forendo Pharma
  • Formula Pharmaceuticals
  • Fortis Healthcare
  • Fortress Biotech
  • Fosun Pharmaceutical
  • Foundation Fighting Blindness
  • Foundation Medicine
  • Fraunhofer IGB
  • Fraunhofer Institute for Molecular Ecology (IME)
  • Fred Hutchinson Cancer Research Center
  • Frequency Therapeutics
  • Friedreichs Ataxia Research Alliance
  • Fujifilm
  • Gadeta
  • Gali Klinik
  • Gamida Cell
  • GammaDelta Therapeutics
  • GC LabCell
  • GE Healthcare
  • Genable Technologies
  • Genentech
  • Gene Therapy Research Institution
  • Genethon
  • Genetic Information Research Institute
  • Genetrix
  • genOway
  • Genprex
  • GenScript USA
  • GenStem Therapeutics
  • GenVec
  • Genzyme
  • George Washington University
  • GeoVax
  • German Research Foundation (DFG)
  • Gestion Univalor
  • Gladstone Institutes
  • GlaxoSmithKline
  • Global Alliance for Innovation in Neuroscience
  • GlycoBac
  • Glycostem Therapeutics
  • Golden Meditech
  • Goliver Therapeutics
  • Government of Canada
  • Great Ormond Street Hospital (GOSH)
  • Grifols
  • Gritstone Oncology
  • Grunenthal
  • Guangzhou Xiangxue Pharmaceutical
  • Gulf Coast Pharmaceuticals
  • Hadassah Medical Center
  • Hamad Bin Khalifa University
  • Harvard Apparatus Regenerative Technology
  • Harvard Medical School
  • Harvard Stem Cell Institute
  • Harvard University
  • Healios K.K.
  • Helix BioPharma
  • Helmholtz Zentrum Munchen
  • HemaCare
  • HemispheRx Biopharma
  • Hemogenyx
  • Henry Schein
  • Hepregen
  • Heraeus
  • HiFiBio
  • Histogen
  • Histogenics
  • Histogen Oncology
  • Hitachi Chemical
  • HitGen
  • Hoba Therapeutics
  • Hong Kong Baptist University
  • Horizon 2020
  • Horizon Discovery
  • Hough Ear Institute
  • HSRx Group
  • HTG Molecular Diagnostics
  • Huapont Pharma
  • Hugel
  • Human Life CORD Japan
  • Human Longevity
  • Huntsworth Health
  • Icahn School of Medicine at Mount Sinai
  • Icon
  • Ideal Medical Solutions
  • ID Pharma
  • Immatics Biotechnologies
  • Immune Therapeutics
  • ImmunoCellular Therapeutics
  • ImmunXperts
  • Immusol
  • Imperial Innovations
  • IMV
  • Incyte
  • Indiana University
  • Induce Biologics
  • Inform Genomics
  • Inhibrx
  • Innate Pharma
  • Innovate UK
  • Innovative Cellular Therapeutics
  • Innovative Genomics Initiative (IGI)
  • Inserm Transfert
  • Institute for Research in Immunology and Cancer – Commercialization of Research
  • Institute of Cancer Research
  • Institute of Child Health
  • Institute Of Molecular Biotechnology
  • Institut Pasteur
  • Integra LifeSciences
  • Intellia Therapeutics
  • IntelliCell BioSciences
  • International Duchenne Alliance
  • International Society for Cellular Therapy
  • International Stem Cell
  • Intrexon
  • inVentiv Health
  • Invetech
  • Invigorcell
  • InVivo Therapeutics
  • INVO Bioscience
  • Ion Channel Innovations
  • Iovance Biotherapeutics
  • iPS Academia Japan
  • ISIS Innovation
  • Isogenica
  • Israeli National Authority for Technological Innovation
  • Janssen Biotech
  • Janssen Pharmaceuticals
  • Jazz Pharmaceuticals
  • JCR Pharmaceuticals
  • Jiangsu Hengrui Medicine
  • John Hopkins University School of Medicines
  • Johns Hopkins University
  • Johnson & Johnson Innovation
  • Joslin Diabetes Center
  • JSR
  • Juno Therapeutics
  • Juvenile Diabetes Research Foundation
  • Juventas Therapeutics
  • Kadimastem
  • Kadmon Pharmaceuticals
  • Kangmei Pharma
  • KangStem Biotech
  • Karolinska Institute
  • Kasios
  • KBI BioPharma
  • Kerecis
  • Kiadis Pharma
  • Kinetic Concepts
  • Kinetic River
  • Kings College London
  • Kite Pharma
  • Kogenix
  • Kolon Life Science
  • KYERON Medical Innovations
  • Kyocera
  • Kyoto University
  • Laboratory Corporation of America
  • Lacerta Therapeutics
  • Lee Moffitt Cancer Center
  • Lehigh University
  • Leiden University
  • LEITAT
  • Lentigen
  • Leona M and Harry B Helmsley Charitable Trust
  • Les Laboratoires Servier
  • Leukemia & Lymphoma Society
  • LG Life Sciences
  • LifeCell
  • LifeLiver
  • LifeSouth Community Blood Centers
  • Live Like Bella Childhood Cancer Foundation
  • Liventa Biosciences
  • Longeveron
  • Lonza
  • Loughborough University
  • Lubeck Institute of Experimental Dermatology
  • Lund University
  • Lung Biotechnology
  • Lupus Foundation of America (LFA)
  • Luye Pharma Group
  • Lysogene
  • M-ERA.Net
  • MabVax Therapeutics
  • Macquarie University
  • MacroCure
  • Magenta Therapeutics
  • MAGiQ Therapeutics
  • Magnetic Insight
  • Magnum Cell Therapies
  • Malaghan Institute
  • Mallinckrodt Pharmaceuticals
  • Marken
  • Maryland Stem Cell Research Fund
  • Massachusetts Eye and Ear Infirmary
  • Massachusetts General Hospital
  • Massachusetts Institute of Technology
  • MaSTherCell
  • Maverick Therapeutics
  • Max-Delbruck Center for Molecular Medicine
  • Max-Planck
  • Maxcyte
  • Mayo Clinic
  • McGill University
  • McKesson
  • MD Anderson Cancer Center
  • Medac
  • Medeor Therapeutics
  • MedGenesis Therapeutix
  • Medgenics
  • Medical Incubator Japan
  • Medical Research Council
  • Medical Technology Enterprise Consortium
  • Medical University of Graz
  • Medicine by Design
  • Medifocus
  • MediGene
  • MedImmune
  • Medinet
  • MediSix Therapeutics
  • Medison Pharma
  • Medisun International
  • Medpace
  • MeiraGTx
  • Memorial Sloan Kettering Cancer Center
  • Merck and Co
  • Merck KGaA
  • Merck Serono
  • Mesoblast
  • Metabolon
  • Metasurg
  • Methuselah Foundation
  • Metrion Biosciences
  • Michael J Fox Foundation
  • Microart
  • Microsoft
  • Mill Creek Life Sciences
  • MilliporeSigma
  • Milo Biotechnology
  • Miltenyi Biotec
  • Minerva Biotechnologies
  • MirImmune
  • Mitsubishi Tanabe Pharma
  • MolMed
  • Monarch Biosciences
  • Montana Board of Research and Commercialization Technology
  • Morphogenesis
  • Mount Tam Biotechnologies
  • MSM-Medimpex
  • MT-Biological Science and Technology
  • Multiclonal Therapeutics
  • Munich Technical University
  • Muscular Dystrophy Association
  • Mustang Bio
  • Myonexus Therapeutics
  • Nanion
  • Nano Dimension
  • nanoRanch
  • NanoString Technologies
  • Nanovis
  • NantKwest
  • Nanyang Technological University
  • NASA
  • National Cancer Centre Singapore
  • National Cancer Institute
  • National Center for Advancing Translational Sciences (NCATS)
  • National Council on Aging
  • National Eye Institute
  • National Healthcare Services (NHS)
  • National Heart
  • Lung and Blood Institute
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Dental and Craniofacial Research (NIDCR)
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Molecular Genetics
  • National Institute of Neurological Disorders and Stroke
  • National Institute of Standards and Technology
  • National Institute on Aging
  • National Institute on Disability and Rehabilitation Research
  • National Institutes of Health
  • National Institutes of Health Center for Regenerative Medicine
  • National Psoriasis Foundation
  • National Stem Cell Foundation
  • National Taiwan University Hospital
  • National University of Ireland
  • Galway (NUI Galway)
  • National University of Singapore
  • Nationwide Children’s Hospital
  • Natural Sciences and Engineering Research Council of Canada
  • Ncardia
  • Neon Therapeutics
  • Nestle Health Science
  • Netherlands Cancer Institute
  • NetScientific
  • Neurocrine Biosciences
  • NeuroVigil
  • New Jersey Innovation Institute
  • New York Presbyterian/Columbia
  • Neximmune
  • NHS Blood and Transplant
  • Nightstar Therapeutics
  • NightstaRx
  • Nikon CeLL Innovation
  • Nkarta Therapeutics
  • Nohla Therapeutics
  • Northwestern University
  • Norwegian Research Council
  • Novartis
  • Novasep
  • Novo Nordisk
  • Nuclea Biotechnologies
  • NuGene International
  • Nuo Therapeutics
  • Nuvilex
  • Obsidian Therapeutics
  • Ocata Therapeutics
  • Ocugen
  • Office of Naval Research
  • Ohio Clinical Trials Collaborative
  • Ohio State University
  • Olaregen Therapeutix
  • Oncolys BioPharma
  • OncoSec Medical
  • Ono Pharmaceutical
  • Ophthotech
  • Orbit Biomedical
  • Orbsen Therapeutics
  • Orchard Therapeutics
  • Oregon Health Sciences University
  • Oregon National Primate Research Center
  • ORFLO Technologies
  • Organogenesis
  • Organovo
  • Organ Technologies
  • Orgenesis
  • ORIG3N
  • Orthocell
  • OrthoCyte
  • Orthohealing Center Management
  • Orthopaedic Research and Education Foundation
  • Ortho Regenerative Technologies
  • OSE Immunotherapeutics
  • Osiris Therapeutics
  • Ospedale San Raffaele
  • Osteo Science Foundation
  • Otologic Pharmaceutics
  • Oxford BioMedica
  • Oxford MEstar
  • OZ Biosciences
  • PACA Inovation
  • PacificGMP
  • Pall Corporation
  • Pan American Cancer Treatment Centers
  • panCELLa
  • Paragon Bioservices
  • Parcell Laboratories
  • Parent Project Muscular Dystrophy
  • Parnell Pharmaceutical Holdings
  • Passage Bio
  • Pathways to Stem Cell Science
  • Paul Ehrlich Institute
  • Paul G Allen Family Foundation
  • PCT
  • PDC*line Pharma
  • Perelman School of Medicine
  • Pfizer
  • PharmaCell
  • PharmaCyte Biotech
  • Phio Pharmaceuticals
  • Pivotal Scientific
  • PlantArcBio
  • PlasmaTech Biopharmaceuticals
  • PlasmidFactory
  • Plasticell
  • Platelet BioGenesis
  • Pluristem Therapeutics
  • Poietis
  • Population Diagnostics
  • Prasco Laboratories
  • Precision BioSciences
  • Premier Inc
  • PreveCeutical Medical
  • Procella Therapeutics
  • Progenitor Cell Therapy
  • ProMab Biotechnologies
  • Promethera Biosciences
  • Prometheus Laboratories
  • Propagenix
  • Prostate Cancer Clinical Trials Consortium
  • Prostate Cancer Foundation (PCF)
  • ProtoKinetix
  • Provecs Medical
  • PsiOxus Therapeutics
  • Puregraft
  • Q Therapeutics
  • Quebec Consortium for Drug Discovery
  • Queensland Institute of Medical Research (QIMR)
  • Ramot at Tel Aviv University
  • Recordati
  • Regen BioPharma
  • Regeneron Pharmaceuticals
  • Regeneus
  • Regentys
  • Regenxbio
  • ReGenX Biosciences
  • ReNeuron
  • Renovacare
  • Renova Therapeutics
  • Renovo
  • Replicel Life Sciences
  • ReproCell
  • Research Development Foundation
  • Research Institute of the Hospital Universitari Vall d'Hebron
  • Research Products Development Company
  • RetroSense Therapeutics
  • Revitope
  • RIKEN Yokohama Institute Omics Science Center
  • Riyadh Pharma
  • Roche
  • Rockefeller University
  • Rocket Pharmaceuticals
  • Rockland Immunochemicals
  • Rohto Pharmaceutical
  • Roivant Sciences
  • ROSLINCT
  • Roswell Park Cancer Institute
  • Royal Free Hospital
  • RTI Surgical
  • Rutgers University
  • RxBio
  • RXi Pharmaceuticals
  • SAFC
  • Salk Institute
  • Sana Biotechnology
  • SanBio
  • Sanford Health
  • Sangamo BioSciences
  • Sanofi
  • San Raffaele Scientific Institute
  • San Raffaele Telethon Institute for Gene Therapy
  • Sapreme Technologies
  • Sarepta Therapeutics
  • SAVSU Technologies
  • Scaled Biolabs
  • Schepens Eye Research Institute
  • ScinoPharm Taiwan
  • SCM Pharma
  • Scottish Enterprise
  • Scripps Research Institute
  • SeaSpine
  • Seattle Children's Hospital
  • Seattle Childrens Research Institute
  • Secant Medical
  • Selecta Biosciences
  • Selexis
  • Semma Therapeutics
  • Sensorion
  • SeouLin Bioscience
  • Seres Therapeutics
  • Sharp Edge Labs
  • Shenzhen Yuanxing Bio-Pharm Science & Technology
  • Shibuya Kogyo
  • Shire Pharmaceuticals
  • Sigilon Therapeutics
  • Sigma-Tau
  • Silver Creek Pharmaceuticals
  • Sinovant Sciences
  • Sirenas
  • Sirion Biotech
  • Sirona Biochem
  • Small Business Innovation Research
  • Smartwise
  • Solentim
  • Somahlution
  • Sorrento Therapeutics
  • Sosei
  • SOTIO
  • Spark Therapeutics
  • Spectrum Pharmaceuticals
  • Spooner Girls Foundation
  • SQZ Biotech
  • St. Jude Children's Research Hospital
  • Stanford University
  • Stanford University School of Medicine
  • Stem Cell Medicine
  • Stem Cell Network
  • StemCell Systems
  • Stemcell Technologies
  • Stemedica Cell Technologies
  • StemExpress
  • Stemlife
  • StemoniX
  • StimLabs
  • St Jude Medical
  • StrideBio
  • Stryker
  • Suneva Medical
  • Sunovion Pharmaceuticals
  • SunTerra Biotechnology
  • Super-T Cell Cancer
  • Surgical Specialties
  • Swedish Orphan Biovitrum
  • Symbiotix Biotherapies
  • SynGen
  • Synpromics
  • Synthego
  • Synthetic Genomics
  • Systagenix Wound Management
  • T-TOP Clinical Research
  • Tactiva Therapeutics
  • TaiGen Biotechnology
  • TaiRx
  • Takara Bio
  • Takeda Pharmaceutical
  • Talee Bio
  • TapImmune
  • Targazyme
  • Target ALS Foundation
  • Targovax
  • Tasly Pharmaceuticals
  • TauTona
  • Taxus Cardium Pharmaceuticals
  • Taxus Pharmaceuticals
  • TC BioPharm
  • TCR2 Therapeutics
  • Team Sanfilippo
  • Technology University Dresden
  • Teijin
  • Tel Aviv Sourasky Medical Center
  • Temple University
  • Terumo BCT
  • Tesaro
  • Tessa Therapeutics
  • Teva Pharmaceutical Industries
  • TFS International
  • TGen Drug Development
  • The American Senior Housing Association
  • The Cell and Gene Therapy Unit
  • The Cyprus Institute of Neurology and Genetics
  • The Global Stem Cell and Regenerative Medicine Acceleration Center (GSRAC)
  • The New York Stem Cell Foundation
  • The Parker Institute For Cancer Immunotherapy
  • TheraBiologics
  • Theragene Pharmaceuticals
  • Therakine
  • Theravectys
  • The Regents of the University of California
  • Thermo Fisher Scientific
  • ThermoGenesis
  • Thiel Foundation
  • Thomas Jefferson University
  • Thorne Research
  • Thrive Bioscience
  • Tianhe Stem Cell Biotechnologies
  • TiGenix
  • TissueGene
  • Tissue Genesis
  • Tissue Regeneration Systems
  • Tiziana Life Sciences
  • Tmunity Therapeutics
  • TNK Therapeutics
  • Torque Therapeutics
  • Touchlight
  • Trakcel
  • Transposagen Biopharmaceuticals
  • Treeway
  • Trianta
  • TriArm Therapeutics
  • Triumvira Immunologics
  • TTFactor
  • Tu Dresden
  • Tulane University
  • TxCell
  • UCL Business
  • UGA Biopharma
  • UK Cystic Fibrosis Gene Therapy Consortium
  • Ulster University
  • UNeMed
  • UniQuest
  • UniQure
  • United Therapeutics
  • Universal Cells
  • Universite Laval
  • University Ann & Robert H. Lurie Children’s Hospital
  • University City Science Center
  • University College London
  • University Health Network
  • University Medical Center Groningen
  • University Medical Center Utrecht
  • University of Adelaide
  • University of Alabama
  • University of Alberta
  • University of Barcelona
  • University of Bern
  • University of Birmingham
  • University of British Columbia
  • University of California
  • University of California
  • Davis
  • University of California
  • San Diego
  • University of California Irvine
  • University of California Los Angeles
  • University of California San Francisco
  • University of Cambridge
  • University of Cologne
  • University of Connecticut
  • University of Edinburgh
  • University of Florida
  • University of Florida Research Foundation
  • University of Illinois at Chicago
  • University of Kentucky
  • University of Lausanne
  • University of Leeds
  • University of Liverpool
  • University of Manchester
  • University of Maryland
  • University of Massachusetts
  • University of Massachusetts
  • Amherst
  • University of Massachusetts Medical School
  • University of Michigan
  • University of Minnesota
  • University of Missouri
  • University of Nebraska
  • University of North Carolina
  • University of Oklahoma
  • University of Oxford
  • University of Pennsylvania
  • University of Pennsylvania School of Veterinary Medicine
  • University of Pittsburgh
  • University of Pittsburgh Medical Center
  • University of Quebec
  • University of Queensland
  • University of Rhode Island
  • University of Rome
  • University of South Florida
  • University of Sydney
  • University of Technology Sydney
  • University of Tennessee
  • University of Texas Southwestern Medical Center
  • University of Tokyo
  • University of Toronto
  • University of Turin
  • University of Victoria-Genome British Columbia Proteomics Centre
  • University of Virginia
  • University of Washington
  • University of Wisconsin-Madison
  • University Pierre Marie Curie
  • Upside Biotechnologies
  • Urovant Sciences
  • US Army
  • US Army Institute of Surgical Research (USAISR)
  • US Army Medical Research and Material Command
  • US Navy
  • US Stem Cell Clinic
  • Vaccine and Gene Therapy Institute of Florida (VGTI-FL)
  • Valitacell
  • Vascugen
  • Vault Bioventures
  • Vaximm
  • VBL Therapeutics (dba)
  • Vectalys
  • Vedanta Biosciences
  • Velabs Therapeutics
  • Vericel
  • Vertex Pharmaceuticals
  • Vet-Stem
  • ViaCyte
  • Videregen
  • Vineti
  • ViraCyte
  • Vir Biotechnology
  • Virginia Biosciences Health Research Corporation
  • Virginia Commonwealth University
  • Visikol
  • VistaGen Therapeutics
  • Vital KSK
  • Vitruvian Networks
  • Vivet Therapeutics
  • ViVex Biomedical
  • Vivo Biosciences
  • Vizient
  • Voyager Therapeutics
  • VWR International
  • Vyriad
  • Waisman Biomanufacturing
  • Walloon Region Investment Fund
  • Washington University in St Louis
  • Weill Cornell Medical College
  • Wellcome Trust
  • Wellcome Trust Sanger Institute
  • WindMIL Therapeutics
  • WIRB-Copernicus Group
  • W L Gore
  • WUGEN
  • Wuxi Apptec Laboratory Services
  • Wylde
  • Xcell Biosciences
  • Xencor
  • Yale University
  • Yeda Research and Development Company
  • YOFOTO (China) Health Industry
  • YUMAB
  • Yumanity Therapeutics
  • Z-Medical
  • Zelluna Immunotherapy
  • Zenalux Biomedical
  • Zhaotai Group
  • Ziopharm Oncology
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/3162392
Adroll
adroll